Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LMA International was a leading global medical device company focused on the development and commercialization of innovative airway management products. The company's flagship product, the Laryngeal Mask Airway (LMA), revolutionized anesthesia practice by providing a less invasive alternative to endotracheal intubation. LMA International offered a broad portfolio of supraglottic airway devices used in both elective surgeries and emergency medicine. In 2012, the company was acquired by Teleflex Incorporated for approximately $276 million, integrating its products into Teleflex's anesthesia and respiratory business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LMA International.